Financial Counselors Inc Pfizer Inc Transaction History

Financial Counselors Inc

$6.18 Billion
Q2 2024

A detailed history of Financial Counselors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Financial Counselors Inc holds 278,482 shares of PFE stock, worth $7.65 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

278,482

Previous 302,744 8.01%

Holding current value

$7.65 Million

Previous $8.4 Million 7.26%

% of portfolio

0.13%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $612,858 - $718,155	-24,262 Reduced 8.01%	278,482 $7.79 Million
Q1 2024 May 02, 2024	SELL	$25.89 - $29.73 $5.63 Million - $6.47 Million	-217,515 Reduced 41.81%	302,744 $8.4 Million
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $1.12 Million - $1.46 Million	-42,890 Reduced 7.62%	520,259 $15 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $170,847 - $199,703	-5,324 Reduced 0.94%	563,149 $18.7 Million
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $38,214 - $44,213	-1,058 Reduced 0.19%	568,473 $20.9 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $257,610 - $335,371	-6,540 Reduced 1.14%	569,531 $23.2 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $206,161 - $269,121	4,938 Added 0.86%	576,071 $29.5 Million
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $179,284 - $218,861	4,097 Added 0.72%	571,133 $25 Million
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $921,014 - $1.09 Million	19,794 Added 3.62%	567,036 $29.7 Million
Q1 2022 Apr 28, 2022	BUY	$45.75 - $56.69 $262,330 - $325,060	5,734 Added 1.06%	547,242 $28.3 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $1.75 Million - $2.6 Million	-42,384 Reduced 7.26%	541,508 $32 Million
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $470,058 - $603,829	-11,976 Reduced 2.01%	583,892 $25.1 Million
Q2 2021 Aug 03, 2021	SELL	$35.91 - $40.68 $181,309 - $205,393	-5,049 Reduced 0.84%	595,868 $23.3 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $236,071 - $266,240	-7,049 Reduced 1.16%	600,917 $21.8 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $1.54 Million - $1.96 Million	-46,020 Reduced 7.04%	607,966 $22.4 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $1.44 Million - $1.69 Million	-45,419 Reduced 6.49%	653,986 $24 Million
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $3.87 Million - $4.7 Million	128,623 Added 22.53%	699,405 $22.9 Million
Q1 2020 Apr 23, 2020	SELL	$27.03 - $38.62 $844,173 - $1.21 Million	-31,231 Reduced 5.19%	570,782 $18.6 Million
Q4 2019 Jan 31, 2020	SELL	$32.92 - $37.36 $34,730 - $39,414	-1,055 Reduced 0.17%	602,013 $23.6 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $852,732 - $1.11 Million	26,246 Added 4.55%	603,068 $21.7 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $492,018 - $552,423	-13,305 Reduced 2.25%	576,822 $25 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $373,612 - $410,475	9,963 Added 1.72%	590,127 $25.1 Million
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $181,578 - $207,019	-4,720 Reduced 0.81%	580,164 $25.3 Million
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $1.48 Million - $1.79 Million	-42,842 Reduced 6.82%	584,884 $25.8 Million
Q2 2018 Aug 03, 2018	SELL	$32.98 - $35.16 $25,559 - $27,248	-775 Reduced 0.12%	627,726 $22.8 Million
Q1 2018 Apr 26, 2018	BUY	$31.91 - $37.02 $199,437 - $231,375	6,250 Added 1.0%	628,501 $22.3 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $131,277 - $139,289	3,947 Added 0.64%	622,251 $22.5 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $9,269 - $10,210	-299 Reduced 0.05%	618,304 $22.1 Million
Q2 2017 Aug 10, 2017	BUY	N/A	618,603	618,603 $20.8 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Pfizer Inc Transaction History